Gold in the ivory tower: equity rewards of outlicensing

Nat Biotechnol. 2006 May;24(5):509-15. doi: 10.1038/nbt0506-509.

Abstract

An analysis of life-science initial public offerings from three time periods reveals that the equity share received by universities and their academic researchers has changed over time.

MeSH terms

  • Biomedical Research / economics*
  • Biotechnology / economics*
  • Biotechnology / legislation & jurisprudence
  • Capital Financing
  • Drug Industry / economics
  • Faculty
  • Intellectual Property
  • Investments*
  • Ownership
  • Private Sector
  • Research Support as Topic
  • Universities*